SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001144204-19-024546
Filing Date
2019-05-08
Accepted
2019-05-08 17:17:51
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B5 tv520841-424b5.htm 424B5 490971
2 GRAPHIC lg_intercept-new.jpg GRAPHIC 28627
  Complete submission text file 0001144204-19-024546.txt   529439
Mailing Address 10 HUDSON YARDS, 37TH FLOOR New York NY 10001
Business Address 10 HUDSON YARDS, 37TH FLOOR NEW YORK NY 10001 646-747-1000
INTERCEPT PHARMACEUTICALS, INC. (Filer) CIK: 0001270073 (see all company filings)

IRS No.: 223868459 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-217861 | Film No.: 19807726
SIC: 2834 Pharmaceutical Preparations